Abstract
Objectives: With growing experience more and more important factors with high influence on short- and long-term effects on TAVI outcome are discovered. However, no testing device for the evaluation of minimal invasive valves has been developed so far. Simultaneously, researchers in cardiovascular TE require increasingly complex bioreactors to simulate physiologic conditions in-vitro. The necessary knowledge of engineering and the rising price quickly become limiting factors for further development. To overcome this problem, we developed the modular dynamic flow testing device Modyflow.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
